2,2,2-trifluoroacetic acid--2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid (1/1)

Catalog No. :
ACXPTZ946
CAS No. :
1415559-41-9
Molecular Formula :
C19H17BrF4N6O6
Molecular Weight :
581.28

IUPAC Name:2,2,2-trifluoroacetic acid--2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid (1/1)

2,2,2-trifluoroacetic acid--2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid (1/1) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2,2-trifluoroacetic acid--2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid (1/1)
IUPAC Name2,2,2-trifluoroacetic acid--2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid (1/1)
Molecular FormulaC19H17BrF4N6O6
Molecular Weight581.28
SMILESO=C(O)C(F)(F)F.O=C(O)CN1N=NC(C2=CC(N3CCC(OC4=C(Br)C=CC(F)=C4)CC3)=NO2)=N1
InChI KeyLEBPCMXFQYATAK-UHFFFAOYSA-N
Synonym(5-{3-[4-(2-Bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl}-2H-tetrazol-2-yl)acetic acid--trifluoroacetic acid (1/1) | 1415559-41-9 | CS-0914 | AKOS027322166 | HY-13077 | MK 8245 Trifluoroacetate | 2-[5-[3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl
CAS No.1415559-41-9
PubChem CID66577003

Synthetic Route by SureRoute

1. ACXPTZ946 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXPTZ946 route product structure diagram
    ACXPTZ9461415559-41-9
Inquiry

2. ACXPTZ946 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXPTZ946 route product structure diagram
    ACXPTZ9461415559-41-9
Inquiry

Comments (0)